Oren Beske, Ph.D.Amalgamator of Business and Biology at ATUM
Profile
Dr. Oren Beske joined ATUM in 2019 and brings nearly 20 years of industry experience to the team. Notably, Dr. Beske was President of Aragen Biosciences, Inc. where he led a multidisciplinary team to bring value added services to the biologics industry. Most recently, he served as the CEO of Alloy Therapeutics, Inc. a start up antibody discovery platform company. Dr. Beske received a BS in Physiology and Biochemistry from CSULB and his Ph.D. in Cell Biology from UC San Francisco.
Agenda Sessions
How ATUM's Integrated Bioengineering Pipeline Brought Support for COVID-19 Diagnostics, Therapeutics and Vaccines. From Virtual Information to Master Cell Bank
On DemandView SessionHow ATUM's Integrated Bioengineering Pipeline Brought Support for COVID-19 Diagnostics, Therapeutics and Vaccines. From Virtual Information to Master Cell Bank.
9:00amView Session